Protein Summary
Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple ...more
- ENST00000282499
- ENSP00000282499
- ENSG00000152578
- ENST00000393125
- ENSP00000376833
- ENST00000428631
- ENSP00000415551
- ENST00000530497
- ENSP00000435775
- GLUR4
- GLUR4
- GLURD
- GluA4
- GLUR4C
- NEDSGA
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
cellular component | 0.92 | ||
molecular function | 0.81 | ||
microRNA | 0.74 | ||
protein domain | 0.73 | ||
ligand (chemical) | 0.72 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 338.66 (req: < 5)
Gene RIFs: 29 (req: <= 3)
Antibodies: 415 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 338.66 (req: >= 5)
Gene RIFs: 29 (req: > 3)
Antibodies: 415 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 3
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 92
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drugs: 6